These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35748821)

  • 21. Serogroup A, C, W, and Y meningococcal disease in persons previously vaccinated with a serogroup ACWY meningococcal vaccine - United States, 2014-2018.
    Blain AE; Reese HE; Marjuki H; Topaz N; Mbaeyi S; McNamara LA
    Vaccine; 2021 Dec; 39(52):7541-7544. PubMed ID: 34802785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Australian Meningococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction.
    Villena R; Valenzuela MT; Bastías M; Santolaya ME
    Vaccine; 2022 Jan; 40(4):666-672. PubMed ID: 34996641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Epidemiology and Trends in Meningococcal Disease-United States, 1996-2015.
    MacNeil JR; Blain AE; Wang X; Cohn AC
    Clin Infect Dis; 2018 Apr; 66(8):1276-1281. PubMed ID: 29126310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactive vaccination as control strategy for an outbreak of invasive meningococcal disease caused by
    Fazio C; Daprai L; Neri A; Tirani M; Vacca P; Arghittu M; Ambrosio L; Cereda D; Gramegna M; Palmieri A; Carannante A; Bertoli MR; Crottogini L; Gennati G; Quinz E; Trezzi L; Ciammaruconi A; Fillo S; Fortunato A; Rezza G; Lista F; Stefanelli P
    Euro Surveill; 2022 Jun; 27(24):. PubMed ID: 35713021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study.
    Ohm M; Hahné SJM; van der Ende A; Sanders EAM; Berbers GAM; Ruijs WLM; van Sorge NM; de Melker HE; Knol MJ
    Clin Infect Dis; 2022 Jul; 74(12):2173-2180. PubMed ID: 34525199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance of invasive meningococcal disease in the south of Brazil: considerations of immunization programme.
    Silveira MM; Crespo da Silva PA; Conrad NL; Oliveira TL; Hartwig DD; Trotter C
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33544069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology and economic burden of meningococcal disease in Germany: A systematic review.
    Gruhn S; Witte J; Greiner W; Damm O; Dietzsch M; Kramer R; Knuf M
    Vaccine; 2022 Mar; 40(13):1932-1947. PubMed ID: 35227520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological burden of meningococcal disease in Brazil: A systematic literature review and database analysis.
    Presa JV; de Almeida RS; Spinardi JR; Cane A
    Int J Infect Dis; 2019 Mar; 80():137-146. PubMed ID: 30641200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
    Guedes S; Bertrand-Gerentes I; Evans K; Coste F; Oster P
    BMC Public Health; 2022 Feb; 22(1):380. PubMed ID: 35197024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of
    Xu J; Chen Y; Yue M; Yu J; Han F; Xu L; Shao Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2071077. PubMed ID: 35687866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of invasive meningococcal disease in Cyprus 2004 to 2018.
    Koliou M; Kasapi D; Mazeri S; Maikanti P; Demetriou A; Skordi C; Agathocleous M; Tzanakaki G; Constantinou E
    Euro Surveill; 2020 Jul; 25(30):. PubMed ID: 32734853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile.
    Villena R; Valenzuela MT; Bastías M; Santolaya ME
    Vaccine; 2019 Oct; 37(46):6915-6921. PubMed ID: 31585728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Australian Meningococcal Surveillance Programme annual report, 2017.
    Lahra MM; Enriquez RP; George CRR
    Commun Dis Intell (2018); 2019 Dec; 43():. PubMed ID: 31838982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing epidemiology of Infant Meningococcal Disease after the introduction of meningococcal serogroup C vaccine in Italy, 2006-2014.
    Stefanelli P; Fazio C; Neri A; Boros S; Renna G; Pompa MG;
    Vaccine; 2015 Jul; 33(31):3678-81. PubMed ID: 26087297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Meningococcal B Vaccine on Invasive Meningococcal Disease in Adolescents.
    McMillan M; Wang B; Koehler AP; Sullivan TR; Marshall HS
    Clin Infect Dis; 2021 Jul; 73(1):e233-e237. PubMed ID: 33587122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meningococcal disease surveillance in the Asia-Pacific region (2020): The global meningococcal initiative.
    Aye AMM; Bai X; Borrow R; Bory S; Carlos J; Caugant DA; Chiou CS; Dai VTT; Dinleyici EC; Ghimire P; Handryastuti S; Heo JY; Jennison A; Kamiya H; Tonnii Sia L; Lucidarme J; Marshall H; Putri ND; Saha S; Shao Z; Sim JHC; Smith V; Taha MK; Van Thanh P; Thisyakorn U; Tshering K; Vázquez J; Veeraraghavan B; Yezli S; Zhu B
    J Infect; 2020 Nov; 81(5):698-711. PubMed ID: 32730999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context.
    Dubey AP; Hazarika RD; Abitbol V; Kolhapure S; Agrawal S
    Hum Vaccin Immunother; 2021 Jul; 17(7):2216-2224. PubMed ID: 33605845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating and Evaluating Tuberculosis Incidence Rates Among People Experiencing Homelessness, United States, 2007-2016.
    Self JL; McDaniel CJ; Bamrah Morris S; Silk BJ
    Med Care; 2021 Apr; 59(Suppl 2):S175-S181. PubMed ID: 33710092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.